Troyen A Brennan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week ago
Troyen A Brennan has an estimated net worth of at least $31.5 million*, as of Dec. 18, 2024. They own 232,676 shares of CVS stock. They have sold 226,405 shares of CVS stock since 2021, for an estimated $20.9 million.
Troyen A Brennan $CVS SEC Form 4 Insider Trading
Troyen A Brennan has filed a total of 5 insider trades in $CVS since 2021. Their most recent trade was a sale of 47,937 shares, made on Feb 03, 2022. Their largest trade was a sale of 80,802 shares, made on Oct 26, 2021. We estimate that they now own 232,676 shares of $CVS, worth an estimated $10.6 million.
Insider Trading at $CVS
There have been a total of 41 insider trades reported at $CVS since 2021, with 30,181 shares purchased and 1.0 million shares sold. The most active insider traders in $CVS stock have been Prem S Shah, Daniel P Finke, and Alan Lotvin. The most recent trade was a purchase of 1,000 shares reported by EDWARD J LUDWIG (None), made on May 02, 2024.
History of Insider Stock Trades by Troyen A Brennan
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
CVS | Sale | 47,937 | Feb 03, 2022 | Feb. 3, 2022, 8 p.m. |
CVS | Sale | 28,159 | Nov 01, 2021 | Nov. 2, 2021, 8 p.m. |
CVS | Sale | 1,955 | Oct 26, 2021 | Oct. 27, 2021, 8 p.m. |
CVS | Sale | 80,802 | Oct 26, 2021 | Oct. 27, 2021, 8 p.m. |
CVS | Sale | 67,552 | Jun 15, 2021 | June 16, 2021, 8 p.m. |
$CVS Executives and Stock Owners with Insider Trades
-
Prem S Shah, EVP and Co-President of Retail
-
Daniel P Finke, EVP/Pres, Health Care Benefits
-
Alan Lotvin, EVP&President-PharmacyServices
-
Thomas M Moriarty, EVP & General Counsel
-
Troyen A Brennan, EVP and Chief Medical Officer
-
James David Clark, SVP, Cont & Chief Acct Officer
-
Jonathan C Roberts, EVP & Chief Operating Officer
-
Karen S Lynch, President and CEO
-
Prem S Shah, EVP and Pres-Pharm, Consumer W
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.